Quantcast

Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr Instagram
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
December 19, 2014, 02:32:12 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 649847
  • Total Topics: 49598
  • Online Today: 161
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online
Users: 1
Guests: 132
Total: 133

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Next step in creating HIV-1 immunotherapy using fossil virus  (Read 820 times)

0 Members and 1 Guest are viewing this topic.

Offline dico

  • Member
  • Posts: 108
Next step in creating HIV-1 immunotherapy using fossil virus
Date:
July 17, 2014
Source:http://www.sciencedaily.com/releases/2014/07/140717125053.htm

The road to finding a cure for HIV-1 is not without obstacles. However, thanks to cutting-edge research by Douglas Nixon, M.D., Ph.D., and colleagues, performed at the George Washington University (GW), Oregon Health & Science University, the University of Rochester, and UC San Francisco, the scientific community is one step closer to finding a viable immunotherapy option for HIV-1, using an immune attack against a fossil virus buried in the genome.

 
A major hurdle in eradicating HIV-1 has been outsmarting the frequent mutations, or changing coats of the virus caused by its high rate of replication. Researchers have focused on neutralizing antibodies directed against the HIV-1 envelope in order to stop the virus, but the antibodies haven't been able to keep up with this constant change. Nixon's research team found that the right antibody directed against an ancestral fossil virus buried within everyone's genomes might be able to target HIV-1 and neutralize it.
"What we've found is an antibody that recognizes these fossil viruses within all our genomes, which can neutralize HIV-1 in a way that has never been seen before," said Nixon, chair of the Department of Microbiology, Immunology, and Tropical Medicine at the GW School of Medicine and Health Sciences. "We have found in vitro, in the test tube, that you can actually have an antibody work against HIV-1, which is not directed against the HIV-1 virus itself."
In his research, Nixon and colleagues found that by targeting the fossil virus -- an ancestral version of a retrovirus that has become a largely useless part of our DNA -- that these antibodies could focus on a single fixed envelope, as it does not change like the constant changes of HIV-1's envelope outer coat. This discovery provides a new, therapeutic target to beat this particular coat, or variation.

Offline dico

  • Member
  • Posts: 108
Re: Next step in creating HIV-1 immunotherapy using fossil virus
« Reply #1 on: July 17, 2014, 04:04:00 PM »
I understand nothing. How can we target a fixed envelope with an antibody and be able to neutralize HIV and its constantly changing envelope ?

Offline Dr.Strangelove

  • Member
  • Posts: 214
Re: Next step in creating HIV-1 immunotherapy using fossil virus
« Reply #2 on: July 19, 2014, 09:10:54 AM »
Yep, that press release is awfully written. Didn't understand a word either when I first read it.

Here's the abstract of the actual article: An Antibody Recognizing Ancestral Endogenous Virus Glycoproteins Mediates Antibody-Dependent Cellular Cytotoxicity on HIV-1–Infected Cells

In the human genome there are evolutionary leftovers of some retroviruses ('fossil virus'). Some non-functional, distant relatives of HIV. They do not produce complete viral particles anymore, but individual genes may still be transcribed and translated into the corresponding proteins.
Researchers found out that in HIV-infected cells, HIV apparently 'accidentally' triggers the expression of those old retroviral genes. The resulting proteins are presented on the surface of the host cell (usually the CD4-cell) and thus visible to the immune system. These proteins are membrane proteins that are related to the glucoprotein complex of HIV (gp41+gp120).
In the publication mentioned above, researchers now found an antibody that can bind to those ancient proteins and thus trigger the destruction of the infected cell by the immune system. The advantage, they say, is that while HIV constantly mutates and thus antibodies directly aimed at HIV-envelope proteins may become useless, the antibody they found against the ancient membrane protein will not be vulnerable to mutation because unlike HIV, those old genes do not mutate.

I simplified a bit, but that's what I got...

Offline dico

  • Member
  • Posts: 108
Re: Next step in creating HIV-1 immunotherapy using fossil virus
« Reply #3 on: July 20, 2014, 02:19:22 AM »
Thank you. It is clearer now.

Very interesting finding but I doubt that latent proviral DNA could be reduced in this way. Indeed latent HIV don't produce virions or proteins...

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.